dc.contributor.author | Hall, E | |
dc.contributor.author | De Bono, J | |
dc.contributor.author | Porta, N | |
dc.contributor.author | Miranda, S | |
dc.contributor.author | Flohr, P | |
dc.contributor.author | Ferreira, A | |
dc.contributor.author | Riisnaes, R | |
dc.contributor.author | Chatfield, P | |
dc.contributor.author | Carreira, S | |
dc.contributor.author | Yuan, W | |
dc.contributor.author | Tunariu, N | |
dc.contributor.author | Espinasse, A | |
dc.contributor.author | Crespo, M | |
dc.contributor.author | Nava Rodrigues, D | |
dc.contributor.author | Gurel, B | |
dc.contributor.author | Clarke, M | |
dc.contributor.author | Curcean, A | |
dc.contributor.author | Pereira, AR | |
dc.contributor.author | Fowler, G | |
dc.contributor.author | Rescigno, P | |
dc.contributor.author | Ebbs, B | |
dc.contributor.author | Bertan, C | |
dc.contributor.author | Seed, G | |
dc.contributor.author | Figueiredo, I | |
dc.date.accessioned | 2019-12-06T14:34:44Z | |
dc.identifier.citation | The Lancet Oncology | |
dc.identifier.issn | 1213-9432 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3443 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.isreplacedby | internal/4110 | |
dc.relation.isreplacedby | https://repository.icr.ac.uk/handle/internal/4110 | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | TOPARP-B: A Randomised Phase 2 Trial Evaluating Two Doses of Olaparib Against Metastatic Castration-Resistant Prostate Cancer With DNA Repair Gene Aberrations | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2019-10-04 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2019-10-04 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | The Lancet Oncology | |
pubs.declined | 2019-12-03T12:04:56.426+0000 | |
pubs.deleted | 2019-12-03T12:04:56.426+0000 | |
pubs.merge-to | internal/4110 | |
pubs.merge-to | https://repository.icr.ac.uk/handle/internal/4110 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/ICR-CTSU Urology and Head and Neck Trials Team | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/ICR-CTSU Urology and Head and Neck Trials Team | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.publication-status | Accepted | |
pubs.embargo.terms | Not known | |
icr.researchteam | Cancer Biomarkers | en_US |
icr.researchteam | Clinical Trials & Statistics Unit | en_US |
icr.researchteam | ICR-CTSU Urology and Head and Neck Trials Team | en_US |
icr.researchteam | Prostate Cancer Targeted Therapy Group | en_US |
dc.contributor.icrauthor | Espinasse, Aude | |
dc.contributor.icrauthor | Gurel, Bora | |
dc.contributor.icrauthor | Pereira, Ana Rita | |
dc.contributor.icrauthor | Rescigno, Pasquale | |
dc.contributor.icrauthor | Hall, Emma | |
dc.contributor.icrauthor | De Bono, Johann | |
dc.contributor.icrauthor | Porta, Nuria | |
dc.contributor.icrauthor | Miranda, Susana | |
dc.contributor.icrauthor | Carreira, Suzanne | |
dc.contributor.icrauthor | Crespo, Mateus | |